Notas del episodio
This module establishes risk assessment as the foundation of treatment decision-making in pulmonary arterial hypertension (PAH). It reviews multidimensional risk stratification, treatment goals, and the use of clinical, functional, biomarker, imaging, and hemodynamic findings to guide initial therapy and subsequent reassessment. Through a high-risk PAH case, the module illustrates how treatment intensity and sequencing should reflect disease severity and clinical trajectory, with timely escalation when low-risk status is not achieved or maintained.
Visit the link in our bio to earn FREE AMA, ABS, ANCC or ACPE credit!